Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer

Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer

Metastatic non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) may suffer from heavy side effects and not all patients benefit from the treatment. We conducted a comprehensive statistical analysis to identify promising (bio-)markers for treatment response. We...

Full description

Bibliographic Details
Main Authors: Stefanie Hiltbrunner, Meta-Lina Spohn, Ramona Wechsler, Dilara Akhoundova, Lorenz Bankel, Sabrina Kasser, Svenja Bihr, Christian Britschgi, Marloes H. Maathuis, Alessandra Curioni-Fontecedro
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
immune checkpoint inhibitors
non-small cell lung cancer
biomarker
basophils
statistical analysis
Online Access:https://www.mdpi.com/2072-6694/14/1/75

Internet

https://www.mdpi.com/2072-6694/14/1/75

Similar Items